Our work confirms and extends these observations by demonstrating the power of FAP to distinguish CMS4 from CMS1-3 (AUC = 0.91) and by providing clinical proof-of-concept for the detection of a CMS4 tumour by FAPI-PET. This evidence concerns the gene FAP and neoplasm.